How Did I Get Chlamydia and My Partner Didn’t?

Chlamydia does not pass between partners every single time they have sex, so one person testing positive while the other tests negative is genuinely common and does not automatically mean someone has been unfaithful. The per-act transmission probability is estimated at roughly 4.5%, and even over the course of an entire partnership, the chance of passing the infection ranges from about 5% to 55% depending on direction and the dataset used. Beyond transmission odds, a negative test in your partner could reflect spontaneous clearance, a test that missed an infection at a different body site, incidental antibiotic treatment, or differences in individual biology. The real answer usually involves more than one of these factors at the same time.

Transmission Is Not a Coin Flip

The single biggest reason one partner can have chlamydia while the other does not is that the bacterium simply does not transmit every time two people have sex. Modeling work estimates the per-act transmission probability at about 4.5%, assuming roughly one unprotected encounter per week in a partnership.¹ That means even with regular unprotected sex over weeks or months, there is a real possibility the infection never makes the jump.

When researchers look at entire partnerships rather than individual sex acts, the numbers are higher but still far from certain. A large evidence synthesis using population survey data from both the UK and the US found that male-to-female transmission probability per partnership was roughly 32–35%, while female-to-male transmission was considerably lower, ranging from about 5% to 21% depending on the dataset.² The wide range in those female-to-male estimates reflects genuine uncertainty in the data, but the direction is consistent: men appear less likely to acquire chlamydia from an infected female partner than the reverse. If you are a man whose female partner tested positive but you tested negative, transmission efficiency alone could explain it.

The type of sex matters too. Mathematical modeling suggests the per-act transmission probability during anal sex is roughly three times higher than during vaginal sex, at about 5.8% versus 2.0%.³ So the specific sexual practices you and your partner engage in shift the odds in ways that can explain discordant results.

Your Partner May Have Already Cleared It

Chlamydia is a bacterial infection, and like other bacterial infections, the immune system sometimes handles it without antibiotics. Spontaneous clearance has been documented in multiple studies, particularly in women. The process appears to involve complex interactions between the bacterium, the host immune system, and the vaginal microbiome.⁴

In one study of women screened for chlamydia in Shenzhen, China, about 24% cleared the infection on their own within a median of 27 days.⁵ That is roughly one in four infected women clearing the bacterium without treatment in under a month. If your partner was exposed around the same time you were, their body may have fought it off before they ever got tested. The natural history of chlamydia is variable and can include persistent asymptomatic infection, complications, or spontaneous resolution.⁶

Spontaneous clearance is less well studied in men, partly because men with urethral chlamydia are more likely to develop noticeable symptoms that prompt treatment. But the principle applies: the immune system can eliminate the infection, and if your partner cleared it before testing, the test would come back negative even though they were previously infected.

The Test Might Have Missed It

Modern chlamydia testing uses nucleic acid amplification tests (NAATs), which are highly sensitive and specific. But “highly sensitive” is not the same as perfect, and the body site tested matters enormously. In women, vaginal swabs detect chlamydia more reliably than urine samples. A meta-analysis found pooled sensitivity of about 94% for vaginal swabs versus 87% for urine.⁷ That gap means a urine-based test in a woman misses roughly one in eight infections.

The bigger problem is extragenital infection. Chlamydia can live in the throat and rectum, and standard screening usually tests only the genitals. In a study of young Black men who have sex with men, about 73% of all chlamydia infections were found only on anal and oral swabs, with no urethral positivity at all.⁸ If your partner was tested only with a urine sample or a genital swab but carried the infection in the throat or rectum, the test would have come back negative despite an active infection.

At-home self-collected swabs for extragenital sites perform comparably to those collected in a clinic, and in one study they actually caught six chlamydia infections that were missed by in-clinic swabs.⁹ The takeaway is that a negative test means “negative at the site tested,” not necessarily “infection-free everywhere.” If there is any chance of oral or anal exposure, testing those sites specifically is the only way to be sure.

False positives, on the other hand, are rare enough that your own positive result almost certainly reflects a real infection. A study that placed dummy samples throughout a clinic environment found no evidence of environmental cross-contamination leading to false positives.¹⁰

Bacterial Load Fluctuates, and That Matters

Chlamydia does not maintain a constant presence in the body. The amount of bacteria someone is shedding varies widely over time, and this has practical consequences for both transmission and detection. Research tracking chlamydia loads over time in anogenital samples found large variations in each patient, both in the initial bacterial load and in how it changed over days and weeks.¹¹

This fluctuation means your partner could have been infected but shedding so little bacteria at the time of their test that the result came back negative. It also means that on days when bacterial load is low, transmission during sex is less likely. The infection can even show intermittent detection, where tests bounce between positive and negative from one sampling to the next. Researchers have documented these “blips” in women after treatment, noting that intermittent positive NAAT results can occur even when culture-based tests (which detect only live bacteria) are negative.¹² Anorectal infections appear to show more intermittent positivity than cervicovaginal ones.¹³

The practical point is that a single negative test represents a snapshot, not a verdict. The bacteria can be present in quantities too low to detect at one moment and easily detectable at another.

Anatomy and Biology Tilt the Odds

Not everyone’s body is equally hospitable to chlamydia. In women, a condition called cervical ectopy, where the type of cells normally found inside the cervical canal are exposed on the outer surface of the cervix, increases susceptibility. These columnar epithelial cells are the ones chlamydia prefers to infect, and their exposure provides a larger target.¹⁴ In a cross-sectional study of high school students in South Africa, women with ectopy had roughly 1.8 times the odds of having chlamydia compared to those without it.¹⁵ Cervical ectopy is more common in younger women and those using hormonal contraception, which partly explains why younger women are disproportionately affected by chlamydia.

Bacterial load also differs by body site. Vaginal swabs tend to yield considerably higher chlamydia loads than anorectal swabs, which in turn carry more bacteria than throat swabs.¹⁶ Higher loads at a given site probably translate into higher transmission risk from that site, which is another reason the same sexual encounter can have very different consequences depending on the anatomy involved.

The Vaginal Microbiome as a Shield

One of the more interesting explanations for why some women seem resistant to chlamydia lies in the bacteria already living in the vagina. Lactobacillus species, particularly Lactobacillus crispatus, produce lactic acid and other compounds that directly interfere with chlamydia’s ability to infect cells. In laboratory experiments, L. crispatus reduced chlamydia infection by about 90%, the strongest effect among the species tested. L. iners, a more ambiguous member of the vaginal community, reduced infection by about 50%.¹⁷

The mechanism goes beyond simple acidification. L. crispatus supernatants nearly eliminated chlamydia’s infectious form even at diluted concentrations, suggesting the bacteria produce specific anti-chlamydial compounds.¹⁸ Further research found that L. crispatus actually changes the surface of cervical cells, reducing exposure of a protein that chlamydia uses to enter cells.¹⁹ So a woman whose vaginal microbiome is dominated by L. crispatus may be substantially more resistant to acquiring chlamydia than one whose microbiome is dominated by less protective species. If you and your partner have different microbiome compositions, the same exposure can produce very different outcomes.

Accidental Treatment With Antibiotics

Here is a scenario that catches many couples off guard: your partner may have been inadvertently cured of chlamydia by antibiotics prescribed for something else entirely. Doxycycline is one of the most commonly prescribed antibiotics in dermatology, used for acne, rosacea, and other skin conditions, and it is also one of the first-line treatments for chlamydia.²⁰ Azithromycin, another common antibiotic given for respiratory infections and sinus infections, was until recently a standard chlamydia treatment as well. If your partner took a course of either drug for an unrelated reason, they may have unknowingly cleared a chlamydia infection without ever knowing they had one.

This is more common than you might think, especially in younger people who are frequently prescribed antibiotics for acne. The infection was there, got wiped out by an unrelated prescription, and by the time testing happens, there is nothing left to find.

Genetic and Immune Differences

Your immune system’s response to chlamydia is not identical to your partner’s, and some of that variation is built into your DNA. Researchers have found that specific gene variants in the human immune system are associated with susceptibility to chlamydia recurrence. Certain HLA class II variants have been linked to increased risk of repeat infections, while variations in the gene controlling the anti-inflammatory molecule IL-10 appeared to be protective against recurrence.²¹

What this means in practical terms is that two people exposed to the same bacterium in the same sexual encounter can mount very different immune responses. One person’s immune system may suppress the infection quickly enough that it never establishes a foothold, while the other’s allows it to persist. Long-term inflammation from chlamydia can lead to tissue remodeling and scarring, and the severity of these consequences also varies by genetic background.²² Immune variation is not something you can control, but it is a legitimate reason why the same exposure produces infection in one person and not in another.

The Awkward Possibility of Different Timelines

Sometimes the answer to “how did I get it if my partner doesn’t have it?” is that you did not get it from your current partner. Chlamydia can persist asymptomatically for months or even longer. If you had a previous sexual partner and were never tested, you could have been carrying the infection since before your current relationship. In that case, your current partner may simply not have acquired it yet, or may have acquired and cleared it.

Self-reported sexual histories are also imperfect. Research on concordance between self-reported STI history and biomedical results has found that social desirability bias affects what people disclose, particularly in face-to-face settings.²³ This is uncomfortable but worth acknowledging: you and your partner may not have complete information about each other’s exposure history, and gaps in that information can make a discordant test result seem more puzzling than it actually is.

The reverse is also true. Your partner could have been the source of the infection but cleared it naturally before testing, leaving you as the only one with a positive result. In that scenario, neither of you did anything wrong, and the discordant result is simply a product of timing.

Not All Chlamydia Strains Behave the Same

Chlamydia trachomatis is not a single uniform organism. It includes multiple genetic variants with distinct properties. Phylogenetic analyses have identified strains that correlate with different disease presentations, including strains linked to lymphogranuloma venereum (a more severe form), typical urethritis and cervicitis, and ocular trachoma.²⁴ Some strains appear to have adapted to prefer certain tissues. In studies comparing men who have sex with men to heterosexual populations, distinct strain clusters emerged, and certain strains showed a preference for rectal tissue over cervical tissue.²⁵²⁶

This tissue tropism means that the particular strain involved could affect whether it takes hold in a given partner’s anatomy. A strain that thrives in rectal tissue may be less efficient at establishing genital infection, or vice versa. The science here is still evolving, but strain diversity adds another variable to the already long list of reasons two people with the same exposure can end up with different test results.

What to Do With a Discordant Result

If you have tested positive and your partner has tested negative, the most productive step is for your partner to get retested, ideally at all potentially exposed body sites, not just with a urine sample. Extragenital testing catches infections that genital-only screening misses. If the negative result holds, the explanations above, either singly or in combination, almost certainly account for the discrepancy.

Both partners should be treated regardless of test results when one partner tests positive. Standard clinical guidelines recommend treating sexual partners of chlamydia-positive individuals because of the high rates of asymptomatic infection and the limitations of single-site testing. Waiting for a confirmatory positive test in the other partner risks ongoing transmission and potential complications. The infection itself is easily cured with a short course of antibiotics, and the conversation about how it got there, while uncomfortable, is usually less mysterious than it first appears.